OPR - Delayed Quote • USD VNDA Sep 2024 3.000 call (VNDA240920C00003000) Follow 1.8000 0.0000 (0.00%) At close: April 25 at 11:37 AM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for VNDA240920C00003000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: VNDA UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know Vanda (VNDA) to Report Q1 Earnings: What's in the Cards? Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents Butler Hall Capital urges Vanda to engage in sales discussions Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
